证券代码：002162 证券简称：悦心健康 上海悦心健康集团股份有限公司投资者关系活动记录表 编号：201601 | --- | --- | --- | |---------------------------|----------------------------|----------------------------------------------------------------------------------------------------------| | 投资者关系活 \n动类别 | √ \n□ \n□ \n□ 现场参观 \n□ | 特定对象调研 □分析师会议 \n媒体采访 □业绩说明会 \n新闻发布会 □路演活动 \n其他 （请文字说明其他活动内容） | | 参与单位名称 及人员姓名 | 1 | 、安信证券 吴晓楠、项君君 | | | 2、平安证券 叶寅 | | | | 3 、上投摩根 | 罗会礼 | | | 4 、域秀资本 | 池陈森 | | | 5 | 、上海互码投资管理合伙企业 周孝勇 | | | | | | | 6 | 、深圳海富凌资本管理有限公司 陈凌 | | 时间 ...

Company Overview - Shanghai Simic Health Environment Technology Co., Ltd. is a subsidiary of Shanghai Yueshin Health Group Co., Ltd. [2] - Established in December 2014, the company implemented an employee stock ownership plan in August 2015, allowing 20% of shares to be held by employees [2]. Product Features - The health board offers excellent water resistance, high moisture absorption, and the ability to release negative ions [3]. - It is resistant to moisture, mold, corrosion, and is non-toxic [3]. - The board has low thermal conductivity, sound absorption, noise reduction, and fire safety rated at A-level [3]. Sales Growth - Health board sales have doubled from the previous year, with sales in the first quarter of this year reaching 160% of the same period last year [4]. - April sales showed significant growth compared to March, with projections indicating this year's sales could reach 2-3 times last year's figures [4]. Trade Show Success - Participation in the 4th China (Shanghai) International Technology Import and Export Fair resulted in positive feedback from government officials, highlighting the health board's innovative features [5]. Air Purification Performance - Formaldehyde purification rate: 30% [7] - Toluene purification rate: 76% [7] - Sustained formaldehyde purification: 93% [7] - TVOC purification rate: 76.4% [7] - Ammonia purification rate: 81.3% [7] User Testimonials - Users report significant improvements in air quality and comfort after installing the health board, with specific cases showing increased negative ion concentrations [17][22][23][38]. Health Benefits - The health board is associated with improved air quality, with negative ion concentrations reaching up to 6130 ions/cm³ in certain installations [23]. - Clinical studies indicate high efficacy rates for respiratory conditions when exposed to negative ions [106]. Environmental Impact - The health board is designed to regulate indoor humidity effectively, contributing to a healthier living environment [42]. - It is suitable for various applications, including military facilities, where it can significantly reduce humidity and improve air quality [51]. Conclusion - The Simic health board represents a significant advancement in building materials, combining health benefits with practical applications for improved indoor air quality and comfort [66].

证券代码：002162 证券简称：悦心健康 上海悦心健康集团股份有限公司投资者关系活动记录表 编号：201605 | --- | --- | --- | |---------------------------|--------------------------|----------------------------------------------------------------------------------------------------------| | 投资者关系活 \n动类别 | √ \n□ \n□ □ 现场参观 \n□ | 特定对象调研 □分析师会议 \n媒体采访 □业绩说明会 \n新闻发布会 □路演活动 \n其他 （请文字说明其他活动内容） | | 参与单位名称 及人员姓名 | 兴业证券 杨子颉 | | | | 金库资本 蔡宜韬、钟玮玮 | | | | | 缠红投资 朱怀鹏、尚娜、张志强 | | | 吴晓楠 | | | 时间 | 2016 年 9 月 6 | 日 | | 地点 | 上海市闵行区恒南路 | 1288 号 101 会议室 | | 上市公司接待 人员姓名 | | 王 ...

证券代码：002162 证券简称：悦心健康 上海悦心健康集团股份有限公司投资者关系活动记录表 编号：201606 | --- | --- | --- | |---------------------------|--------------------------|----------------------------------------------------------------------------------------------------------| | 投资者关系活 \n动类别 | √ \n□ \n□ □ 现场参观 \n□ | 特定对象调研 □分析师会议 \n媒体采访 □业绩说明会 \n新闻发布会 □路演活动 \n其他 （请文字说明其他活动内容） | | 参与单位名称 及人员姓名 | | 陈宇哲、张沫涵 东方证券 | | | 陈子木 | 博道投资 | | | 张诗悦 兴业基金 | | | | 毛楠 长信基金 | | | | 张洋 | 中原证券资产管理总部 | | | 戴炯瀚 | 财通基金 | | 时间 | 2016 年 11 | 月 3 日 | | 地点 | 上海市闵行区恒南路 | ...

打造大中华优生健康的第一服务品牌 悦心健康妇幼生殖遗传专科医院 提醒与声明 | --- | --- | |----------------------------------------------|----------------------------------------| | | 本报告内容中所涉及的关于项目未来经营数 | | 据，包括项目数量、投资规模、营收规模、获利、 | | | 现金流量、及其他相关数据，均为根据目前有限 | | | 的行业市场信息进行初步预估，目的只在帮助投 | | | 资者了解项目未来的发展规划情况，因此，相关 | | | 预估数据存在重大的不确定性，与未来实际经营 | | | 结果可能存在重大差异，请投资者注意投资风险。 | | 2 辅助生殖市场超过千亿市场 国内供不应求 市场规 模测算 ■中国人口协会公布的调查结果显示，中国不孕不育患 者已超过4000万。体外受精的单次费用在2-4万元左右, 根据15%的就医率，对应的市场规模在1200亿以上 总体供 不应求 不孕不育市场规模上升 √不孕不育率上升(环境因素，生育年龄后移)； √二胎放开，再生意愿增强； √诊断和治疗技术 ...

证券代码：002162 证券简称：悦心健康 上海悦心健康集团股份有限公司投资者关系活动记录表 编号：201703 | --- | --- | --- | |---------------------------|-----------------------------|----------------------------------------------------------------------------------------------------------| | 投资者关系活 \n动类别 | √ \n□ \n□ □ 现场参观 \n□ | 特定对象调研 □分析师会议 \n媒体采访 □业绩说明会 \n新闻发布会 □路演活动 \n其他 （请文字说明其他活动内容） | | 参与单位名称 及人员姓名 | 天风证券 吴晓楠 | | | | 宏信证券 张睿、刘冉、叶惠利 | | | | | 上海正淄资产管理有限公司 沈浩 | | | | 誉华资产管理（上海）有限公司 李雪莹 | | | 千般资本 陈菲 | | | | 必达控股集团有限公司 张峥 | | | | | 上海隽诚投资咨询有限公司 张鸣 | ...

证券代码：002162 证券简称：悦心健康 上海悦心健康集团股份有限公司投资者关系活动记录表 编号：201702 | --- | --- | --- | |---------------------------|---------------------------------------|----------------------------------------------------------------------------------------------------------| | 投资者关系活 \n动类别 | √ \n□ \n□ □ 现场参观 \n□ | 特定对象调研 □分析师会议 \n媒体采访 □业绩说明会 \n新闻发布会 □路演活动 \n其他 （请文字说明其他活动内容） | | 参与单位名称 及人员姓名 | 中银基金医药研究员 梦圆 康桥资本 汪今 | | | | | | | 时间 | 2017 年 7 月 11 | 日 15:00-16:30 | | 地点 | 上海市恒南路 | 1288 号 5 楼会议室 | | 上市公司接待 人员姓名 | | 宋源诚、朱庆伟、程梅、王小莹 | ...

| --- | --- | --- | |-------|-------|-------| | | | | | | : 60 EVERJOY HEALTH GROUP 视 您 如 己 ·全 心 关 爱 | | | --- | --- | --- | --- | |-------|-------|-------|-------| | | | | | | | | | | 报 告 大 纲 1. 悦心愿景及战略布局 2. 本次重组摘要 1. 本次交易背景及概览 2. 标的资产业务概览 3. 本次交易对本公司的影响 3. 投后经营管理、展望未来 1. 引进海外医疗资源 2. 开展国际转诊 3. 建构区域医院集团 1. 悦心愿景及战略布局 2. 本次重组摘要 1. 本次交易背景及概览 2. 标的资产业务概览 3. 本次交易对本公司的影响 3. 投后经营管理、展望未来 | --- | --- | --- | --- | |-------|-------|------------------|-------| | | | | | | | 1. | 引进海外医疗资源 | | | | 2. | 开展国际转诊 | | | | 3. ...

Group 1: Investor Relations Activity - The investor relations activity was held on July 3, 2017, from 15:00 to 18:00 at the Shanghai Guoxin Zijinshan Hotel [4] - Participants included representatives from various investment firms and asset management companies [1][2][3] Group 2: Company Overview and Strategy - The company aims to integrate resources to enhance medical service levels and contribute to the health sector [4] - The strategic focus includes leveraging medical resources from Taiwan and educational resources from universities to build a health platform [4] - The company plans to operate light-asset elderly care projects to establish a foundation for integrated medical and elderly care [4] Group 3: Major Asset Restructuring - The restructuring involves three target hospitals, with a focus on their operational backgrounds and the impact on the company [5] - The company intends to introduce overseas medical resources and develop international referral services [5] - The restructuring is expected to enhance the company's operational management and financial performance [5][6] Group 4: Financial Projections and Performance - The company anticipates that the medical insurance income from the hospitals will gradually increase due to rising resident incomes [10] - The hospitals are expected to achieve significant revenue growth, particularly in oncology and rehabilitation services [7][8] - The projected increase in hospital capacity includes the addition of 500 beds at Fenjinting Hospital [9] Group 5: Future Development and Market Position - The company aims to become the largest regional hospital alliance with a target of 100 hospitals [6] - The integration of advanced management models from the U.S. and Taiwan is expected to improve local healthcare standards [6] - The company plans to maintain a dual focus on both the health industry and its traditional tile business, adapting strategies as necessary [8][9]

Group 1: Company Overview - Shanghai Yueshen Health Group was established in 1993, focusing on building ceramics and healthcare services [3] - The company has a well-known brand "Simik" in the building ceramics industry, maintaining good operating cash flow [3] - In 2015, the company shifted its strategy towards the healthcare and elderly care industry, which has shown initial success [3] Group 2: Healthcare and Elderly Care Business - The company operates a dual asset model in elderly care, focusing on integrated services in the Yangtze River Delta region [4] - The occupancy rate of the Hangzhou Third Welfare Institute, managed by the company since June 2017, has reached 90% [5] - A new CCRC community project in partnership with the Minhang District government in Shanghai is set to be completed next year [5] Group 3: Ceramics Business - The sales revenue from the B-end ceramics business accounts for approximately 25% [5] - The company collaborates with major real estate developers such as Xuhui Real Estate and Baolong Real Estate [5] Group 4: Financial Performance - The company has good revenue, gross margin, and cash flow, but low net profit due to high asset depreciation [6] - The relocation of the ceramics production line to Jiangxi has resulted in high fixed asset investment and depreciation costs [6] Group 5: Future Development Plans - The company plans to develop a "Yueshen Health Science and Technology Innovation Park" on nearly 600 acres of land in Shanghai [4][7] - The park will focus on smart health medical research and development, supported by technology finance and training [4] - The company is preparing for future development and financial impact assessments to balance short-term investments and long-term returns [7]